Does neurorehabilitation have a role in relapsing-remitting multiple sclerosis?

Journal of Neurology

Volumn 250, Issue 10, 2003, Pages 1214-1218

  Liu, Clarence ^a   Playford, E Diane ^a   Thompson, Alan J ^a  

^a NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

Disability; Multiple sclerosis; Rehabilitation; Relapsing remitting

Indexed keywords

STEROID;

ADULT; ARTICLE; CONTROLLED STUDY; CONVALESCENCE; CORRELATION ANALYSIS; DISEASE CLASSIFICATION; DISEASE EXACERBATION; DISEASE SEVERITY; FUNCTIONAL ASSESSMENT; HUMAN; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; RECURRENT DISEASE; REHABILITATION MEDICINE; REMISSION; STEROID THERAPY; TREATMENT OUTCOME; VISUAL ANALOG SCALE;

ADULT; DISABLED PERSONS; DISEASE PROGRESSION; FEMALE; HUMANS; INPATIENTS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; PATIENT SATISFACTION; PERIODICITY; RECURRENCE; RETROSPECTIVE STUDIES; STEROIDS; TREATMENT OUTCOME;

EID: 0142011049     PISSN: 03405354     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00415-003-0187-0     Document Type: Article

References (24)

1. Barkhof F, Polman C (1997) Oral or intravenous methylprednisolone for acute relapses of MS? Lancet 349: 893-894
2. Barnes D, Hughes RA, Morris RW, Wade-Jones O, Brown P, Britton T, et al. (1997) Randomised trial of oral and intravenous methylprednisolone in acute relapses of multiple sclerosis. Lancet 349:902-906
3. Bethoux F, Miller DM, Kinkel RP (2001) Recovery following acute exacerbations of multiple sclerosis: from impairment to quality of life. Mult Scler 7:137-142
4. rd edition. Churchill Livingstone, London, pp 437-498
5. Compston A, Coles A (2002) Multiple sclerosis. Lancet 359:1221-1231
6. Edwards SG, Playford ED, Hobart JC, Thompson AJ (2002) Comparison of physician outcome measures and patients' perception of benefits of inpatient neurorehabilitation. BMJ 324:1493
7. Fitzpatrick R, Davey C, Buxton MJ, Jones DR (1998) Evaluating patient-based outcome measures for use in clinical trials. Health Technol Assessment 2:14
8. Freeman JA, Langdon DW, Hobart JC, Thompson AJ (1997) The impact of inpatient rehabilitation on progressive multiple sclerosis. Ann Neurol 42: 236-244
9. Freeman JA, Langdon DW, Hobart JC, Thompson AJ (1999) Inpatient rehabilitation in multiple sclerosis: do the benefits carry over into the community? Neurology 52:50-56
10. Freeman JA, Playford ED, Nicholas RS, Thompson AJ (1996) A neurological rehabilitation unit: audit of activity and outcome. J R Coll Physicians Lond 30:21-26
11. Hobart J, Freeman J, Thompson A (2000) Kurtzke scales revisited: the application of psychometric methods to clinical intuition. Brain 123:1027-1040
12. Keith RA, Granger CV, Hamilton BB, Sherwin FS (1987) The functional independence measure: a new tool for rehabilitation. Adv Clin Rehabil 1:6-18
13. Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33:1444-1452
14. Kurtzke JF, Beebe GW, Nagler B, Auth TL, Kurland LT, Nefzger MD (1973) Studies on the natural history of multiple sclerosis. 7. Correlates of clinical change in an early bout. Acta Neurol Scand 49:379-395
15. Lublin F, Cutter G, Baier M (2002) The role of exacerbations in persistent impairment in MS. Mult Scler 8 (Suppl 1): S7
16. Lublin FD, Reingold SC (1996) Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology 46:907-911
17. Mahoney FI, Barthel DW (1965) Functional evaluation: the Barthel Index. Md State Med J 14:61-65
18. Matthews WB (1991) Course and prognosis. In: Matthews WB, Compston DAS, Allen IV, Martyn CN (eds) McAlpine's multiple sclerosis 2nd edition. Churchill Livingstone, Edinburgh, pp 139-163
19. Petajan JH, Gappmaier E, White AT, Spencer MK, Mino L, Hicks RW (1996) Impact of aerobic training on fitness and quality of life in multiple sclerosis. Ann Neurol 39:432-441
20. Prineas JW, Barnard RO, Kwon EE, Sharer LR, Cho E-S (1993) Multiple sclerosis: remyelination of nascent lesions. Ann Neurol 33:137-151
21. Sharrack B, Hughes RA, Soudain S, Dunn G (1999) The psychometric properties of clinical rating scales used in multiple sclerosis. Brain 122: 141-159
22. Solari A, Filippini G, Gasco P, Colla L, Salmaggi A, La Mantia L, et al. (1999) Physical rehabilitation has a positive effect on disability in multiple sclerosis patients. Neurology 52:57-62
23. Weinshenker BG, Rice GP, Noseworthy JH, Carriere W, Baskerville J, Ebers GC (1991) The natural history of multiple sclerosis: a geographically based study. 3. Multivariate analysis of predictive factors and models of outcome. Brain 114:1045-1056
24. Wiles CM, Newcombe RG, Fuller KJ, Shaw S.Furnival-Doran J, Pickersgill TP, et al. (2001) Controlled randomised crossover trial of the effects of physiotherapy on mobility in chronic multiple sclerosis. J Neurol Neurosurg Psychiatry 70:174-179